[1]庞晓燕,王晓华,冀云鹏,等.2020~2022年呼和浩特地区0~1岁儿童巨细胞病毒感染的血清学检测及危险因素分析[J].现代检验医学杂志,2025,40(05):153-157.[doi:10.3969/j.issn.1671-7414.2025.05.029]
 PANG Xiaoyan,WANG Xiaohua,JI Yunpeng,et al.Serologic Testing and Risk Factor Analysis of Human Cytomegalovirus Infection in Children Aged 0~1 Years in Hohhot Region, 2020~2022[J].Journal of Modern Laboratory Medicine,2025,40(05):153-157.[doi:10.3969/j.issn.1671-7414.2025.05.029]
点击复制

2020~2022年呼和浩特地区0~1岁儿童巨细胞病毒感染的血清学检测及危险因素分析()

《现代检验医学杂志》[ISSN:/CN:]

卷:
第40卷
期数:
2025年05期
页码:
153-157
栏目:
论著
出版日期:
2025-09-15

文章信息/Info

Title:
Serologic Testing and Risk Factor Analysis of Human Cytomegalovirus Infection in Children Aged 0~1 Years in Hohhot Region, 2020~2022
文章编号:
1671-7414(2025)05-153-05
作者:
庞晓燕王晓华冀云鹏李 璐宋月欣周雪原
内蒙古自治区妇幼保健院遗传优生科/医学遗传学内蒙古自治区工程研究中心,呼和浩特 010020
Author(s):
PANG XiaoyanWANG XiaohuaJI YunpengLI LuSONG YuexinZHOU Xueyuan
Department of Genetics Eugenics, Maternital and Child Health Hospital of Inner Mongolia/Inner Mongolia Autonomous Region Engineering Research Center of Medical Genetics,Hohhot 010020,China
关键词:
人巨细胞病毒感染血清学检测母乳喂养阴道分娩危险因素
分类号:
R373.11;R446.6
DOI:
10.3969/j.issn.1671-7414.2025.05.029
文献标志码:
A
摘要:
目的研究0~1岁儿童巨细胞病毒(CMV)血清学流行率和感染状况,探讨CMV感染的危险因素,为临床提供参考。方法回顾性分析2020年1月~2022年12月内蒙古自治区妇幼保健院儿内科门诊或住院部就诊的所有行化学发光(CL)法检测TORCH的0~1岁4938例患儿资料,了解该地区儿童人巨细胞病毒(HCMV)血清流行率,结合实验室检测结果和临床信息,分析HCMV感染的相关危险因素。结果4938例患儿总抗体阳性率94.01%(4642/4938),总IgG抗体阳性率93.86%(4635/4938),总IgM抗体阳性率8.10%(400/4938),两者同时检出阳性率为7.96%(393/4938)。不同年龄组之间HCMV-IgG和HCMV-IgM抗体阳性率比较,差异具有统计学意义(χ2=36.350,1043.199,均P<0.05);男童与女童HCMV-IgG和IgM抗体阳性率比较,差异无统计学意义(χ2=0.215,1.184,均P>0.05)。经单因素分析,感染组母乳喂养率和阴道分娩率高于对照组,喂养方式和出生方式差异具有统计学意义(χ2=10.777,5.725,均P<0.05)。多因素分析发现,母乳喂养和阴道分娩是HCMV感染的独立危险因素,差异具有统计学意义(Waldχ2=6.247,10.057,均P<0.05)。结论?1岁内儿童HCMV血清学抗体阳性率高达94.01%,3~6月龄婴儿最易感染。母乳喂养和经阴道分娩是1岁内儿童HCMV感染的独立危险因素。
Abstract:
Objective To understand the serologic prevalence and infection status of Cytomegalovirus(CMV)in children aged 0~1 years, and explore the risk factors of CMV infection for clinical reference. Methods The data of 4 938 children aged 0~1 years who underwent chemiluminescence enzyme immunoassay for TORCH in Department of Inpatient and Department of Pediatrics Outpatient of Maternal and Child Health Hospital of Inner Mongolia from January 2020 to December 2022 were retrospectively analyzed to understand the seroprevalence of human CMV (HCMV) among children in the region, and analyzed the risk factors associated with HCMV infections by combining the results of laboratory tests and clinical information. Results In 4 938 children, the total antibody positivity rate was 94.01% (4 642/4 938),the total IgG antibody positivity rate was 93.86% (4 635/4 938), the total IgM antibody positivity rate was 8.10% (400/4 938),and the positive rate of the two simultaneous detections was 7.96% (393/4 938). The difference in HCMV-IgG and HCMV-IgM antibodies positivity rates beteen different age groups were statistically significant (χ2=36.350,1 043.199,all P<0.05), and the differences in HCMV-IgG and IgM antibodies between boys and girls were not statistically significant (χ2=0.215, 1.184,all P>0.05). According to univariate analysis, the breast-feeding and vaginal delivery rates in the infected group were higher than those in the control group, and the differences in feeding and birth methods were statistically significant (χ2=10.777, 5.725, all P<0.05). Multifactorial analysis found that breast-feeding and transvaginal delivery were independent risk factors for HCMV infection,and the differences was statistically significant (Wald χ2=6.247, 10.057, all P<0.05). Conclusion The serologic antibody positivity rate of HCMV in children within 1 year of age is as high as 94.01%, and infants aged 3 months to 6 months are most susceptible to infection. Breastfeeding and transvaginal delivery are independent risk factors for HCMV infection in children within 1 year of age.

参考文献/References:

[1] LI W, LIU L F, TAO R, et al. Epidemiological characteristics of human Cytomegalovirus infection and glycoprotein H genotype in Chinese children[J]. Pediatrics and Neonatology, 2020, 61(1): 63-67.
[2] 刘逦玮.围生期巨细胞病毒感染的影响因素及回顾性临床研究[D].上海:上海交通大学,2014. LIU L W.The retrospective cohort study of effect factors, clinical feature of perinatal Cytomegalovirus infection in infants[D]. Shanghai: Shanghai Jiaotong University, 2014.
[3] DE CUYPER E, ACKE F, KEYMEULEN A, et al. Risk factors for hearing loss at birth in newborns with congenital Cytomegalovirus infection[J]. JAMA Otolaryngology Head Neck Surgery, 2023, 149(2): 122-130.
[4] CANNON M J, STOWELL J D, CLARK R, et al. Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy Cytomegalovirus-seropositive children [J]. BMC Infectious Diseases, 2014, 14: 569.
[5] SARTORI P, EGLOFF C, HCINI N, et al. Primary, secondary, and tertiary prevention of congenital Cytomegalovirus infection [J]. Viruses, 2023, 15(4): 819.
[6] LEVIT Y, DYM L, YOCHPAZ S, et al. Assessment of risk indicators for targeted Cytomegalovirus screening in neonates[J]. Neonatology, 2020, 117(6): 750-755.
[7] 中华医学会儿科学分会感染学组,全国儿科临床病毒感染协作组,《中华儿科杂志》编辑委员会. 儿童巨细胞病毒性疾病诊断和防治的建议[J].中华儿科杂志,2012,50(4):290-292. The Subspecialty Group of Infectious Diseases, The Society of Pediatrics, Chinese Medical Association, National Pediatric Clinical Virology Cooperative Group,The Editorial Board of Chinese Journal of Pediatrics. A proposal for the diagnosis, treatment and prophylaxis of Cytomegalovirus diseases in children[J] .Chinese Journal of Pediatrics, 2012, 50(4): 290-292.
[8] 左江成,邓琛琛,杨洁,等.湖北宜昌市育龄妇女和母婴巨细胞病毒感染现状调查及感染风险评估[J].现代检验医学杂志,2020,35(6):91-94, 148. ZUO J C, DENG C C, YANG J, et al. Investigation on status and risk assessment of Cytomegalovirus infection in women of childbearing age and maternals and infants in Yichang, Hubei[J]. Journal of Modern Laboratory Medicine, 2020, 35(6): 91-94, 148.
[9] NAVTI O B, AL-BELUSHI M, KONJE J C, et al. Cytomegalovirus infection in pregnancy - an update [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021, 258: 216-222.
[10] JENKS C M, HOFF S R, MITHAL L B. Congenital Cytomegalovirus infection: epidemiology, timely diagnosis, and management[J]. NeoReviews, 2021, 22(9): e606-e613.
[11] 吴美玲,陈洁,钟天鹰,等.南京市0~8岁儿童巨细胞病毒感染流行病学调查[J].中华实用儿科临床杂志,2013,28(4):298-300. WU M L, CHEN J, ZHONG T Y, et al. Seroprevalence of Cytomegalovirus infection in children aged 0 ~ 8 years in nanjing[J]. Chinese Journal of Applied Clinical Pediatrics, 2013, 28(4): 298-300.
[12] 曾庆贺,肖立燕,孟艳,等.枣庄地区0~12岁儿童人巨细胞病毒感染的流行病学调查[J].中国妇幼健康研究,2020,31(9):1180-1184. ZENG Q H, XIAO L Y, MENG Y, et al. Epidemiological survey of human Cytomegalovirus infection in children aged 0~12 years in Zaozhuang region[J]. Chinese Journal of Woman and Child Health Research, 2020, 31(9): 1180-1184.
[13] 马婷婷,刘义庆,路超,等.山东地区0~12岁儿童人巨细胞病毒抗体阳性特征分析[J].国际检验医学杂志,2018,39(10):1188-1190. MA T T, LIU Y Q, LU C, et al. Analysis of positive features of Cytomegalovirus antibody in children aged 0 ~ 12 years in Shandong[J]. International Journal of Laboratory Medicine, 2018, 39(10): 1188-1190.
[14] 北京地区母婴巨细胞病毒感染课题组.婴儿期巨细胞病毒感染对生长发育影响的前瞻性研究[J].中华儿科杂志,2010,48(5):385-389. Beijing Maternal and Child Cytomegalovirus Infection Research Group. Prospective study on the impact of infantile Cytomegalovirus infection on growth and development of infants [J]. Chinese Journal of Pediatrics, 2010, 48(5): 385-389.
[15] TAKEMOTO K, OSHIRO M, SATO Y, et al. Outcomes in symptomatic preterm infants with postnatal Cytomegalovirus infection[J]. Nagoya Journal of Medical Science, 2021, 83(2): 311-319.
[16] 童笑梅.早产儿经母乳获得性巨细胞病毒感染:疑虑与挑战[J].中国小儿急救医学,2021,28(2):102-106. TONG X M. Breast milk acquired Cytomegalovirus infections in premature infants: doubts and challenges[J]. Chinese Pediatric Emergency Medicine, 2021, 28(2): 102-106.
[17] 刘胜,何杰书.母婴喂养方式与分娩方式对婴儿巨细胞感染的影响情况分析[J].智慧健康,2022, 8(5):79-81, 85. LIU S, HE J S. Analysis on the influence of maternal and infant feeding method and delivery method on infant giant cell infection [J]. Smart Healthcare, 2022, 8(5): 79-81, 85.
[18] KAYE S, MILES D, ANTOINE P, et al. Virological and immunological correlates of mother-to-child transmission of Cytomegalovirus in the Gambia[J]. Journal of Infectious Diseases, 2008, 197(9): 1307-1314.
[19] KASAI R, TORIYABE K, GOTO T, et al. A case of breast milk-acquired Cytomegalovirus infection in an extremely low birth weight infant[J]. Journal of Neonatal Perinatal Medicine, 2023, 16(2): 343-348.
[20] SAITO K, TANAKA K, NAKAGAWA R, et al. Handling of human milk to prevent acquired Cytomegalovirus infection in Japanese neonatal intensive care units: the first nationwide survey[J]. Pediatrics International, 2024, 66(1): e15728.
[21] BARDANZELLU F, FANOS V, REALI A. Human breast milk-acquired Cytomegalovirus infection:certainties, doubts and perspectives[J]. Current Pediatric Reviews, 2019, 15(1): 30-41.
[22] 张顺先.先天性巨细胞病毒感染状况及随访研究[D].北京: 中国疾病预防控制中心, 2013. ZHANG S X. Research of infection rates and follow-up for congenital Cytomegalovirus infection[D]. Beijing:Chinese Center for Disease Control and Prevention, 2013.
[23] ZHAO P, MA D X, XUE F Z, et al. Seroprevalence and risk factors of human Cytomegalovirus infection in the eastern Chinese population[J]. Archives of Virology, 2009, 154(4): 561-564.
[24] BALEGAMIRE S J, MCCLYMONT E, CROTEAU A, et al. Prevalence, incidence, and risk factors associated with Cytomegalovirus infection in healthcare and childcare worker: a systematic review and meta-analysis[J]. Systematic Reviews, 2022, 11(1): 131.
[25] 房丽娜.妊娠期糖尿病与新生儿巨细胞病毒感染的相关性调查研究[D].青岛:青岛大学,2019. FANG L N.Study on the relationship between pregnancy diabetes and Cytomegalovirus infection in neonates[D]. Qingdao: Qingdao University, 2019.

相似文献/References:

[1]齐冰,孙蔚.肺间质纤维化并发肺气肿病人血清TGF-β,VEGF和IGF-I作用、意义及与吸烟相关性研究[J].现代检验医学杂志,2015,30(06):109.[doi:10.3969/j.issn.1671-7414.2015.06.033]
 QI Bing,SUN Wei.Research on the Significance and Role of the Serum TGF-β,VEGF, IGF-Ⅰand Its Correlation with Smoking of the Patients with Combined Pulmonary Fibrosis and Emphysema[J].Journal of Modern Laboratory Medicine,2015,30(05):109.[doi:10.3969/j.issn.1671-7414.2015.06.033]
[2]俞 斌.2015 ~ 2019 年湖北省临床实验室抗甲型肝炎病毒抗体IgM能力验证(EQA)结果回顾分析[J].现代检验医学杂志,2020,35(04):158.[doi:10.3969/j.issn.1671-7414.2020.04.040]
 YU Bin.Retrospective Analysis of IgM Validation Results of Anti-hepatitis A Virus Antibody in Hubei Clinical Laboratory from 2015 to 2019[J].Journal of Modern Laboratory Medicine,2020,35(05):158.[doi:10.3969/j.issn.1671-7414.2020.04.040]

备注/Memo

备注/Memo:
基金项目:内蒙古自治区妇幼保健院院内科研项目(2024FYYNC033)。
作者简介:庞晓燕(1994-),女,硕士研究生,主管检验师,从事临床分子微生物检验工作,E-mail: 1295156732@qq.com。
通讯作者:周雪原(1986-),女,硕士研究生,主管检验师,从事临床分子微生物检验工作, E-mail: 382263699@qq.com。
更新日期/Last Update: 2025-09-15